We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Recently, the global innovative drug R&D company Hope Medicine Inc. announced the completion of a Series B financing US$56 million. This round of financing was jointly led by Qiming Venture Partners and Grand Flight Investment. HighLight Capital (HLC) ...